Burgess CD, Windom HH, Pearce N, Marshall S, Beasley R, Siebers RW, Crane J (February 1991). "Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma". The American Review of Respiratory Disease. 143 (2): 444–6. doi:10.1164/ajrccm/143.2.444. PMID1671326.
Beasley R, Pearce N, Crane J, Burgess C (1995). "Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic". International Archives of Allergy and Immunology. 107 (1–3): 325–7. doi:10.1159/000237016. PMID7613161.
Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R (April 1989). "Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study". Lancet. 1 (8644): 917–22. doi:10.1016/s0140-6736(89)92505-1. PMID2565417. S2CID22765551.
Beasley R, Pearce N, Crane J, Burgess C (1995). "Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic". International Archives of Allergy and Immunology. 107 (1–3): 325–7. doi:10.1159/000237016. PMID7613161.
Beasley R, Burgess C, Pearce N, Woodman K, Crane J (July 1994). "Confounding by severity does not explain the association between fenoterol and asthma death". Clinical and Experimental Allergy. 24 (7): 660–8. doi:10.1111/j.1365-2222.1994.tb00970.x. PMID7953948. S2CID24043007.
Burgess CD, Windom HH, Pearce N, Marshall S, Beasley R, Siebers RW, Crane J (February 1991). "Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma". The American Review of Respiratory Disease. 143 (2): 444–6. doi:10.1164/ajrccm/143.2.444. PMID1671326.
Beasley R, Pearce N, Crane J, Burgess C (1995). "Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic". International Archives of Allergy and Immunology. 107 (1–3): 325–7. doi:10.1159/000237016. PMID7613161.
Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R (April 1989). "Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study". Lancet. 1 (8644): 917–22. doi:10.1016/s0140-6736(89)92505-1. PMID2565417. S2CID22765551.
Beasley R, Pearce N, Crane J, Burgess C (1995). "Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic". International Archives of Allergy and Immunology. 107 (1–3): 325–7. doi:10.1159/000237016. PMID7613161.
Beasley R, Burgess C, Pearce N, Woodman K, Crane J (July 1994). "Confounding by severity does not explain the association between fenoterol and asthma death". Clinical and Experimental Allergy. 24 (7): 660–8. doi:10.1111/j.1365-2222.1994.tb00970.x. PMID7953948. S2CID24043007.
Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R (April 1989). "Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study". Lancet. 1 (8644): 917–22. doi:10.1016/s0140-6736(89)92505-1. PMID2565417. S2CID22765551.
Beasley R, Burgess C, Pearce N, Woodman K, Crane J (July 1994). "Confounding by severity does not explain the association between fenoterol and asthma death". Clinical and Experimental Allergy. 24 (7): 660–8. doi:10.1111/j.1365-2222.1994.tb00970.x. PMID7953948. S2CID24043007.